Tag

Bharatkumar R. Desai

1 article

Bharat Parenterals FY26 Results: Dividend, Loss Narrowing

• Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with unmodified audit opinions. • Recommended final dividend of ₹1.00 per equity share (10%)